SOPHiA GENETICS SA (SOPH)

SOPHiA GENETICS executives have engaged in significant selling activity recently, totaling nearly five million dollars. These planned and proposed divestments follow a period where the stock price surged by 59.9%. Despite the negative earnings report, leadership continues executing pre-arranged sales, reflecting a pattern of liquidity events among key management personnel during this high valuation phase.
Ticker: SOPH Exchange: NSM


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for SOPHiA GENETICS SA. Upgrade to see score, net flow, insiders and the full signal context.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Xu Zhenyu Chief Scientific Officer Officer
Transaction date
Planned sale
Price
181.80
Quantity 14,909 -10.0%
Value US$4,136,131
Menu Philippe Chief Medical Officer Officer
Transaction date
Planned sale
Price
66.26
Quantity 96,607 +35.4%
Value US$3,144,217
Camblong Jurgi Executive Chairman Executive Director
Transaction date
Planned sale
Price
242.93
Quantity 97,539 +30.1%
Value US$3,611,657
Camblong Jurgi Executive Chairman Executive Director
Transaction date
Planned sale
Price
7.23
Quantity 1,000 -0.6%
Value US$100,000
Verma Abhimanyu Chief Technology Officer Officer
Transaction date
Planned sale
Price
7.60
Quantity 1,000 -2.7%
Value US$100,000
Xu Zhenyu Chief Scientific Officer Officer
Transaction date
Planned sale
Price
7.48
Quantity 1,000 -1.7%
Value US$100,000
Xu Zhenyu Chief Scientific Officer Officer
Transaction date
Planned sale
Price
7.02
Quantity 1,000 -1.2%
Value US$100,000
ZHENYU XU Officer Officer
Transaction date
Proposed sale
Price
6.69
Quantity 1,000
Value US$100,000
JURGI CAMBLONG Director; Officer Executive Director
Transaction date
Proposed sale
Price
6.69
Quantity 1,000
Value US$100,000
Xu Zhenyu Chief Scientific Officer Officer
Transaction date
Planned sale
Price
7.00
Quantity 1,000 -0.5%
Value US$100,000
Xu Zhenyu Chief Scientific Officer Officer
Transaction date
Planned sale
Price
6.92
Quantity 1,000 -1.6%
Value US$100,000
Camblong Jurgi Executive Chairman Executive Director
Transaction date
Planned sale
Price
6.92
Quantity 1,000 -0.6%
Value US$100,000
Verma Abhimanyu Chief Technology Officer Officer
Transaction date
Planned sale
Price
6.95
Quantity 1,000 -2.6%
Value US$100,000
ZHENYU XU Officer Officer
Transaction date
Proposed sale
Price
5.69
Quantity 1,000
Value US$100,000
JURGI CAMBLONG Director; Officer Executive Director
Transaction date
Proposed sale
Price
5.69
Quantity 1,000
Value US$100,000
Menu Philippe Chief Medical Officer Officer
Transaction date
Planned sale
Price
5.66
Quantity 1,000 -2.2%
Value US$100,000
Camblong Jurgi Executive Chairman Executive Director
Transaction date
Planned sale
Price
6.63
Quantity 20,000 -0.6%
Value US$132,654
JURGI CAMBLONG Director; Officer Executive Director
Transaction date
Proposed sale
Price
6.33
Quantity 37,000
Value US$234,210
Camblong Jurgi Executive Chairman Executive Director
Transaction date
Planned sale
Price
6.17
Quantity 4,581 -0.1%
Value US$28,244
Camblong Jurgi Executive Chairman Executive Director
Transaction date
Planned sale
Price
6.32
Quantity 19,800 -0.6%
Value US$125,201
JURGI CAMBLONG Director; Officer Executive Director
Transaction date
Proposed sale
Price
5.87
Quantity 24,381
Value US$143,116
Menu Philippe Chief Medical Officer Officer
Transaction date
Planned sale
Price
5.70
Quantity 5,000 -2.1%
Value US$28,505
Xu Zhenyu Chief Scientific Officer Officer
Transaction date
Planned sale
Price
5.70
Quantity 4,000 -0.7%
Value US$22,819
Camblong Jurgi Executive Chairman Executive Director
Transaction date
Planned sale
Price
5.62
Quantity 8,500 -0.2%
Value US$47,791
Camblong Jurgi Executive Chairman Executive Director
Transaction date
Planned sale
Price
5.28
Quantity 17,685 -0.5%
Value US$93,327
JURGI CAMBLONG Director; Officer Executive Director
Transaction date
Proposed sale
Price
5.34
Quantity 24,290
Value US$129,709
Camblong Jurgi Executive Chairman Executive Director
Transaction date
Planned sale
Price
5.26
Quantity 22,486 -0.6%
Value US$118,164
Valente Manuela Chief People Officer Officer
Transaction date
Planned sale
Price
5.05
Quantity 4,241 -2.0%
Value US$21,430
2.0
CARDOZA GEORGE Chief Financial Officer Officer
Transaction date
Planned sale
Price
5.29
Quantity 1,592 -0.5%
Value US$8,419
Menu Philippe Chief Medical Officer Officer
Transaction date
Planned sale
Price
5.16
Quantity 7,393 -3.1%
Value US$38,156
Muken Ross Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
5.22
Quantity 9,838 -1.4%
Value US$51,354
Xu Zhenyu Chief Scientific Officer Officer
Transaction date
Planned sale
Price
5.17
Quantity 7,393 -1.2%
Value US$38,242
1.3
Puylaert Kevin Chief Sales Officer Officer
Transaction date
Sale
Price
5.09
Quantity 31 -0.0%
Value US$158
1.3
Puylaert Kevin Chief Sales Officer Officer
Transaction date
Sale
Price
5.03
Quantity 47 -0.0%
Value US$236
1.3
Puylaert Kevin Chief Sales Officer Officer
Transaction date
Sale
Price
5.03
Quantity 138 -0.1%
Value US$693
Verma Abhimanyu Chief Technology Officer Officer
Transaction date
Planned sale
Price
5.10
Quantity 5,285 -2.7%
Value US$26,957
PHILIPPE MENU Officer Officer
Transaction date
Proposed sale
Price
5.35
Quantity 32,393
Value US$173,303
ZHENYU XU Officer Officer
Transaction date
Proposed sale
Price
5.35
Quantity 19,393
Value US$103,753
2.0
GEORGE CARDOZA Officer Officer
Transaction date
Proposed sale
Price
5.35
Quantity 1,592
Value US$8,517
ROSS J MUKEN Officer Officer
Transaction date
Proposed sale
Price
5.35
Quantity 9,838
Value US$52,633
MANUELA VALENTE Officer Officer
Transaction date
Proposed sale
Price
5.35
Quantity 4,241
Value US$22,689
Camblong Jurgi Executive Chairman Executive Director
Transaction date
Planned sale
Price
6.30
Quantity 200 -0.0%
Value US$1,260
Camblong Jurgi Executive Chairman Executive Director
Transaction date
Planned sale
Price
6.02
Quantity 19,650 -0.5%
Value US$118,322
Camblong Jurgi Executive Chairman Executive Director
Transaction date
Planned sale
Price
6.14
Quantity 45,419 -1.2%
Value US$279,050
JURGI CAMBLONG Director; Officer Executive Director
Transaction date
Proposed sale
Price
5.98
Quantity 70,000
Value US$418,600
Camblong Jurgi Executive Chairman Executive Director
Transaction date
Planned sale
Price
6.00
Quantity 350 -0.0%
Value US$2,100
Camblong Jurgi Executive Chairman Executive Director
Transaction date
Planned sale
Price
5.87
Quantity 18,060 -0.5%
Value US$105,958
JURGI CAMBLONG Director; Officer Executive Director
Transaction date
Proposed sale
Price
5.75
Quantity 20,000
Value US$115,000
Camblong Jurgi Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
5.84
Quantity 31,940 -0.9%
Value US$186,395
Camblong Jurgi Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
5.73
Quantity 18,129 -0.5%
Value US$103,934
JURGI CAMBLONG Director; Officer Executive Director
Transaction date
Proposed sale
Price
5.69
Quantity 68,129
Value US$387,654
Camblong Jurgi Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
5.70
Quantity 1,373 -0.0%
Value US$7,826
Verma Abhimanyu Chief Technology Officer Officer
Transaction date
Planned sale
Price
5.51
Quantity 6,944 -3.4%
Value US$38,229
Menu Philippe Chief Medical Officer Officer
Transaction date
Planned sale
Price
5.50
Quantity 5,000 -2.0%
Value US$27,524
JURGI CAMBLONG Director; Officer Executive Director
Transaction date
Proposed sale
Price
5.52
Quantity 1,373
Value US$7,579
2.0
CARDOZA GEORGE Chief Financial Officer Officer
Transaction date
Planned sale
Price
5.38
Quantity 774 -0.2%
Value US$4,164
Muken Ross President Officer
Transaction date
Planned sale
Price
5.38
Quantity 422 -0.1%
Value US$2,270
ROSS J MUKEN Officer Officer
Transaction date
Proposed sale
Price
5.46
Quantity 422
Value US$2,304
ROSS J MUKEN Officer Officer
Transaction date
Proposed sale
Price
5.46
Quantity 422
Value US$2,304
2.0
GEORGE CARDOZA Officer Officer
Transaction date
Proposed sale
Price
5.46
Quantity 774
Value US$4,226
Xu Zhenyu Chief Scientific Officer Officer
Transaction date
Planned sale
Price
5.01
Quantity 4,000 -0.6%
Value US$20,056
Menu Philippe Chief Medical Officer Officer
Transaction date
Planned sale
Price
4.95
Quantity 5,000 -2.0%
Value US$24,752
Camblong Jurgi Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
5.24
Quantity 8,500 -0.2%
Value US$44,501
2.0
CARDOZA GEORGE Chief Financial Officer Officer
Transaction date
Purchase
Price
4.95
Quantity 20,000 +6.9%
Value US$99,000
2.0
CARDOZA GEORGE Chief Financial Officer Officer
Transaction date
Purchase
Price
4.95
Quantity 20,000 +6.9%
Value US$99,000
Menu Philippe Chief Medical Officer Officer
Transaction date
Planned sale
Price
4.95
Quantity 5,000 -2.0%
Value US$24,774
Camblong Jurgi Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
4.60
Quantity 4,486 -0.1%
Value US$20,658
Xu Zhenyu Chief Scientific Officer Officer
Transaction date
Planned sale
Price
4.60
Quantity 608 -0.1%
Value US$2,798
1.3
Puylaert Kevin Chief Sales Officer Officer
Transaction date
Sale
Price
4.54
Quantity 33 -0.0%
Value US$150
Valente Manuela Chief People Officer Officer
Transaction date
Planned sale
Price
4.60
Quantity 380 -0.2%
Value US$1,747
Muken Ross President Officer
Transaction date
Planned sale
Price
4.60
Quantity 761 -0.1%
Value US$3,501
Van Well Daan Chief Legal Officer Officer
Transaction date
Planned sale
Price
4.60
Quantity 684 -0.2%
Value US$3,149
Menu Philippe Chief Medical Officer Officer
Transaction date
Planned sale
Price
4.61
Quantity 608 -0.2%
Value US$2,800
MANUELA VALENTE Officer Officer
Transaction date
Proposed sale
Price
4.69
Quantity 380
Value US$1,782
DAAN GUIDO MARIA VAN WELL Officer Officer
Transaction date
Proposed sale
Price
4.69
Quantity 684
Value US$3,208
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Value Details
2026-08-14 2026-08-13 PlS Planned sale

Chief Scientific Officer

Officer
14,909 -10.0%
181.80
US$4,136,131
14,909 -10.0% 181.80 US$4,136,131
2026-08-14 2026-08-12 PlS Planned sale

Chief Medical Officer

Officer
96,607 +35.4%
66.26
US$3,144,217
96,607 +35.4% 66.26 US$3,144,217
2026-08-10 2026-08-10 PlS Planned sale

Executive Chairman

Executive Director
97,539 +30.1%
242.93
US$3,611,657
97,539 +30.1% 242.93 US$3,611,657
2026-08-10 2026-08-07 PlS Planned sale

Executive Chairman

Executive Director
1,000 -0.6%
7.23
US$100,000
1,000 -0.6% 7.23 US$100,000
2026-08-10 2026-08-07 PlS Planned sale

Chief Technology Officer

Officer
1,000 -2.7%
7.60
US$100,000
1,000 -2.7% 7.60 US$100,000
2026-08-07 2026-08-07 PlS Planned sale

Chief Scientific Officer

Officer
1,000 -1.7%
7.48
US$100,000
1,000 -1.7% 7.48 US$100,000
2026-08-07 2026-08-07 PlS Planned sale

Chief Scientific Officer

Officer
1,000 -1.2%
7.02
US$100,000
1,000 -1.2% 7.02 US$100,000
2026-08-07 2026-08-07 PrS Proposed sale

Officer

Officer
1,000
6.69
US$100,000
1,000 6.69 US$100,000
2026-08-07 2026-08-07 PrS Proposed sale

Director; Officer

Executive Director
1,000
6.69
US$100,000
1,000 6.69 US$100,000
2026-08-07 2026-08-05 PlS Planned sale

Chief Scientific Officer

Officer
1,000 -0.5%
7.00
US$100,000
1,000 -0.5% 7.00 US$100,000
2026-08-05 2026-08-04 PlS Planned sale

Chief Scientific Officer

Officer
1,000 -1.6%
6.92
US$100,000
1,000 -1.6% 6.92 US$100,000
2026-08-05 2026-08-04 PlS Planned sale

Executive Chairman

Executive Director
1,000 -0.6%
6.92
US$100,000
1,000 -0.6% 6.92 US$100,000
2026-08-05 2026-08-04 PlS Planned sale

Chief Technology Officer

Officer
1,000 -2.6%
6.95
US$100,000
1,000 -2.6% 6.95 US$100,000
2026-08-04 2026-08-04 PrS Proposed sale

Officer

Officer
1,000
5.69
US$100,000
1,000 5.69 US$100,000
2026-08-04 2026-08-04 PrS Proposed sale

Director; Officer

Executive Director
1,000
5.69
US$100,000
1,000 5.69 US$100,000
2026-07-28 2026-07-27 PlS Planned sale

Chief Medical Officer

Officer
1,000 -2.2%
5.66
US$100,000
1,000 -2.2% 5.66 US$100,000
2026-07-22 2026-07-21 PlS Planned sale

Executive Chairman

Executive Director
20,000 -0.6%
6.63
US$132,654
20,000 -0.6% 6.63 US$132,654
2026-07-21 2026-07-21 PrS Proposed sale

Director; Officer

Executive Director
37,000
6.33
US$234,210
37,000 6.33 US$234,210
2026-07-22 2026-07-20 PlS Planned sale

Executive Chairman

Executive Director
4,581 -0.1%
6.17
US$28,244
4,581 -0.1% 6.17 US$28,244
2026-07-22 2026-07-20 PlS Planned sale

Executive Chairman

Executive Director
19,800 -0.6%
6.32
US$125,201
19,800 -0.6% 6.32 US$125,201
2026-07-20 2026-07-20 PrS Proposed sale

Director; Officer

Executive Director
24,381
5.87
US$143,116
24,381 5.87 US$143,116
2026-07-14 2026-07-13 PlS Planned sale

Chief Medical Officer

Officer
5,000 -2.1%
5.70
US$28,505
5,000 -2.1% 5.70 US$28,505
2026-07-14 2026-07-13 PlS Planned sale

Chief Scientific Officer

Officer
4,000 -0.7%
5.70
US$22,819
4,000 -0.7% 5.70 US$22,819
2026-07-14 2026-07-10 PlS Planned sale

Executive Chairman

Executive Director
8,500 -0.2%
5.62
US$47,791
8,500 -0.2% 5.62 US$47,791
2026-07-08 2026-07-07 PlS Planned sale

Executive Chairman

Executive Director
17,685 -0.5%
5.28
US$93,327
17,685 -0.5% 5.28 US$93,327
2026-07-07 2026-07-07 PrS Proposed sale

Director; Officer

Executive Director
24,290
5.34
US$129,709
24,290 5.34 US$129,709
2026-07-07 2026-07-06 PlS Planned sale

Executive Chairman

Executive Director
22,486 -0.6%
5.26
US$118,164
22,486 -0.6% 5.26 US$118,164
2026-07-07 2026-07-06 PlS Planned sale

Chief People Officer

Officer
4,241 -2.0%
5.05
US$21,430
4,241 -2.0% 5.05 US$21,430
2026-07-07 2026-07-06 PlS Planned sale

Chief Financial Officer

Officer
1,592 -0.5%
5.29
US$8,419
1,592 -0.5% 5.29 US$8,419
2026-07-07 2026-07-06 PlS Planned sale

Chief Medical Officer

Officer
7,393 -3.1%
5.16
US$38,156
7,393 -3.1% 5.16 US$38,156
2026-07-07 2026-07-06 PlS Planned sale

Chief Executive Officer

Executive Director
9,838 -1.4%
5.22
US$51,354
9,838 -1.4% 5.22 US$51,354
2026-07-07 2026-07-06 PlS Planned sale

Chief Scientific Officer

Officer
7,393 -1.2%
5.17
US$38,242
7,393 -1.2% 5.17 US$38,242
2026-07-07 2026-07-06 S Sale

Chief Sales Officer

Officer
31 -0.0%
5.09
US$158
31 -0.0% 5.09 US$158
2026-07-07 2026-07-06 S Sale

Chief Sales Officer

Officer
47 -0.0%
5.03
US$236
47 -0.0% 5.03 US$236
2026-07-07 2026-07-06 S Sale

Chief Sales Officer

Officer
138 -0.1%
5.03
US$693
138 -0.1% 5.03 US$693
2026-07-07 2026-07-06 PlS Planned sale

Chief Technology Officer

Officer
5,285 -2.7%
5.10
US$26,957
5,285 -2.7% 5.10 US$26,957
2026-07-06 2026-07-06 PrS Proposed sale

Officer

Officer
32,393
5.35
US$173,303
32,393 5.35 US$173,303
2026-07-06 2026-07-06 PrS Proposed sale

Officer

Officer
19,393
5.35
US$103,753
19,393 5.35 US$103,753
2026-07-06 2026-07-06 PrS Proposed sale

Officer

Officer
1,592
5.35
US$8,517
1,592 5.35 US$8,517
2026-07-06 2026-07-06 PrS Proposed sale

Officer

Officer
9,838
5.35
US$52,633
9,838 5.35 US$52,633
2026-07-06 2026-07-06 PrS Proposed sale

Officer

Officer
4,241
5.35
US$22,689
4,241 5.35 US$22,689
2026-07-01 2026-06-30 PlS Planned sale

Executive Chairman

Executive Director
200 -0.0%
6.30
US$1,260
200 -0.0% 6.30 US$1,260
2026-07-01 2026-06-30 PlS Planned sale

Executive Chairman

Executive Director
19,650 -0.5%
6.02
US$118,322
19,650 -0.5% 6.02 US$118,322
2026-07-01 2026-06-30 PlS Planned sale

Executive Chairman

Executive Director
45,419 -1.2%
6.14
US$279,050
45,419 -1.2% 6.14 US$279,050
2026-06-30 2026-06-30 PrS Proposed sale

Director; Officer

Executive Director
70,000
5.98
US$418,600
70,000 5.98 US$418,600
2026-07-01 2026-06-29 PlS Planned sale

Executive Chairman

Executive Director
350 -0.0%
6.00
US$2,100
350 -0.0% 6.00 US$2,100
2026-07-01 2026-06-29 PlS Planned sale

Executive Chairman

Executive Director
18,060 -0.5%
5.87
US$105,958
18,060 -0.5% 5.87 US$105,958
2026-06-29 2026-06-29 PrS Proposed sale

Director; Officer

Executive Director
20,000
5.75
US$115,000
20,000 5.75 US$115,000
2026-06-29 2026-06-26 PlS Planned sale

Chief Executive Officer

Executive Director
31,940 -0.9%
5.84
US$186,395
31,940 -0.9% 5.84 US$186,395
2026-06-29 2026-06-26 PlS Planned sale

Chief Executive Officer

Executive Director
18,129 -0.5%
5.73
US$103,934
18,129 -0.5% 5.73 US$103,934
2026-06-26 2026-06-26 PrS Proposed sale

Director; Officer

Executive Director
68,129
5.69
US$387,654
68,129 5.69 US$387,654
2026-06-29 2026-06-25 PlS Planned sale

Chief Executive Officer

Executive Director
1,373 -0.0%
5.70
US$7,826
1,373 -0.0% 5.70 US$7,826
2026-06-26 2026-06-25 PlS Planned sale

Chief Technology Officer

Officer
6,944 -3.4%
5.51
US$38,229
6,944 -3.4% 5.51 US$38,229
2026-06-26 2026-06-25 PlS Planned sale

Chief Medical Officer

Officer
5,000 -2.0%
5.50
US$27,524
5,000 -2.0% 5.50 US$27,524
2026-06-25 2026-06-25 PrS Proposed sale

Director; Officer

Executive Director
1,373
5.52
US$7,579
1,373 5.52 US$7,579
2026-06-23 2026-06-22 PlS Planned sale

Chief Financial Officer

Officer
774 -0.2%
5.38
US$4,164
774 -0.2% 5.38 US$4,164
2026-06-23 2026-06-22 PlS Planned sale

President

Officer
422 -0.1%
5.38
US$2,270
422 -0.1% 5.38 US$2,270
2026-06-22 2026-06-22 PrS Proposed sale

Officer

Officer
422
5.46
US$2,304
422 5.46 US$2,304
2026-06-22 2026-06-22 PrS Proposed sale

Officer

Officer
422
5.46
US$2,304
422 5.46 US$2,304
2026-06-22 2026-06-22 PrS Proposed sale

Officer

Officer
774
5.46
US$4,226
774 5.46 US$4,226
2026-06-17 2026-06-15 PlS Planned sale

Chief Scientific Officer

Officer
4,000 -0.6%
5.01
US$20,056
4,000 -0.6% 5.01 US$20,056
2026-06-15 2026-06-12 PlS Planned sale

Chief Medical Officer

Officer
5,000 -2.0%
4.95
US$24,752
5,000 -2.0% 4.95 US$24,752
2026-06-11 2026-06-10 PlS Planned sale

Chief Executive Officer

Executive Director
8,500 -0.2%
5.24
US$44,501
8,500 -0.2% 5.24 US$44,501
2026-06-05 2026-06-05 B Purchase

Chief Financial Officer

Officer
20,000 +6.9%
4.95
US$99,000
20,000 +6.9% 4.95 US$99,000
2026-06-05 2026-06-05 B Purchase

Chief Financial Officer

Officer
20,000 +6.9%
4.95
US$99,000
20,000 +6.9% 4.95 US$99,000
2026-06-01 2026-05-26 PlS Planned sale

Chief Medical Officer

Officer
5,000 -2.0%
4.95
US$24,774
5,000 -2.0% 4.95 US$24,774
2026-05-20 2026-05-19 PlS Planned sale

Chief Executive Officer

Executive Director
4,486 -0.1%
4.60
US$20,658
4,486 -0.1% 4.60 US$20,658
2026-05-20 2026-05-19 PlS Planned sale

Chief Scientific Officer

Officer
608 -0.1%
4.60
US$2,798
608 -0.1% 4.60 US$2,798
2026-05-20 2026-05-19 S Sale

Chief Sales Officer

Officer
33 -0.0%
4.54
US$150
33 -0.0% 4.54 US$150
2026-05-20 2026-05-19 PlS Planned sale

Chief People Officer

Officer
380 -0.2%
4.60
US$1,747
380 -0.2% 4.60 US$1,747
2026-05-20 2026-05-19 PlS Planned sale

President

Officer
761 -0.1%
4.60
US$3,501
761 -0.1% 4.60 US$3,501
2026-05-20 2026-05-19 PlS Planned sale

Chief Legal Officer

Officer
684 -0.2%
4.60
US$3,149
684 -0.2% 4.60 US$3,149
2026-05-20 2026-05-19 PlS Planned sale

Chief Medical Officer

Officer
608 -0.2%
4.61
US$2,800
608 -0.2% 4.61 US$2,800
2026-05-19 2026-05-19 PrS Proposed sale

Officer

Officer
380
4.69
US$1,782
380 4.69 US$1,782
2026-05-19 2026-05-19 PrS Proposed sale

Officer

Officer
684
4.69
US$3,208
684 4.69 US$3,208